BB Biotech AG 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 3:46 pm Purchase | 2024-01-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 9,194,064 5.100% | 5,000,000 (+119.22%) | Filing |
| 2024-01-24 3:21 pm Unchanged | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,194,064 3.700% | 0 (Unchanged) | Filing |
| 2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,194,064 5.700% | -283,900 (-6.34%) | Filing |
| 2022-02-11 4:39 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,477,964 7.100% | 0 (Unchanged) | Filing |
| 2021-05-28 5:00 pm Purchase | 2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,477,964 15.900% | 530,000 (+13.42%) | Filing |
| 2021-05-27 4:33 pm Purchase | 2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,477,964 15.900% | 1,085,000 (+31.98%) | Filing |
| 2021-02-12 4:58 pm Purchase | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 3,947,964 14.200% | 220,000 (+5.90%) | Filing |
| 2020-02-14 2:36 pm Purchase | 2019-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 3,727,964 13.600% | 905,000 (+32.06%) | Filing |